Actively Recruiting

Age: 2Years +
All Genders
ID05769621

A Retrospective Cohort Study to Characterize Propionic Acidemia Patients

Led by ModernaTX, Inc. · Updated on 2026-02-05

60

Participants Needed

29

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to describe the characteristics, clinical outcomes, and event rates in participants with propionic acidemia (PA), a rare metabolic disorder. It is a non-interventional, observational, global, multicenter study that collects data retrospectively from medical records to better understand PA over time. Data will be gathered by reviewing medical records from various study sites, including hospitals, clinics, and academic centers. Participants included will be those diagnosed with PA confirmed by genetic testing, with records documenting specific metabolic events. The study will cover up to 10 years of medical history and events. Participants' involvement consists of allowing researchers to review their medical records to collect information about metabolic decompensation events, hospitalizations, and urgent healthcare visits related to PA. Researchers will analyze the number and severity of these events, along with hospitalization data, to understand PA's clinical impact. The study does not involve direct treatment or interventions and focuses on data collection and analysis.

CONDITIONS

Brief Title

A Retrospective Study to Characterize Participants With Propionic Acidemia

Who Can Participate

Age: 2Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed diagnosis of propionic acidemia by molecular genetic testing of PCCA and/or PCCB mutations
  • Participant provided informed consent and assent, if applicable
  • Medical records with sufficient data for event adjudication available from birth or January 1, 2015, whichever is later
  • Experienced at least one metabolic decompensation event in the 24 months before the index date or at least three such events within any 12-month period since birth or January 1, 2015
  • Confirmed age of disease onset (early or late, with early defined as neonatal period)
  • Participants meeting censoring criteria may enroll if they have at least 2 years of data before censoring and meet all inclusion criteria based on available data
Not Eligible

You will not qualify if you...

  • Participation in any clinical study of an investigational agent
  • Received gene therapy treatment
  • Confirmed organ transplantation
  • Investigator unable to obtain relevant clinical information
  • Death
  • Prior or ongoing participation in clinical study mRNA-3927-P101 (NCT04159103) or mRNA-3927-P101-EXT (NCT05130437)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Medical Record Review

Duration - Up to 10 years of historical data

Participants' medical records are retrospectively reviewed to collect data relevant to propionic acidemia and clinical events.

No visits; data collection from existing medical records

Trial Site Locations

Total: 29 locations

1

University of Stanford Medical Center

Stanford, California, United States, 94305-2200

Not Yet Recruiting

2

Johns Hopkins University

Baltimore, Maryland, United States, 21287-0010

Actively Recruiting

3

University of Michigan Hospital

Ann Arbor, Michigan, United States, 48109-5000

Active, Not Recruiting

4

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

5

Texas Children's Hospital

Houston, Texas, United States, 77030-2614

Terminated

6

Seattle Children's Hospital

Seattle, Washington, United States, 98105-3901

Actively Recruiting

7

Royal Children's Hospital Melbourne

Parkville, Victoria, Australia, 3052

Withdrawn

8

Stollery Children's Hospital University of Alberta

Edmonton, Alberta, Canada, T6G 2B7

Withdrawn

9

CHU Toulouse

Toulouse, Haute-Garonne, France, 31300

Actively Recruiting

10

CHRU Nancy Hôpital des Enfants

Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France, 54511

Withdrawn

11

Hôpital Necker - Enfants Malades

Paris, Paris, France, 75743

Actively Recruiting

12

CHU de Marseille - Hôpital de la Timone

Marseille, France, 13386

Actively Recruiting

13

Azienda Ospedaliera Universitaria Federico II

Naples, Campania, Italy, 80131

Actively Recruiting

14

ASST di Monza - Azienda Ospedaliera San Gerardo

Monza, Monza A Brianza, Italy, 20900

Active, Not Recruiting

15

Azienda Ospedaliero Universitaria A Meyer - INCIPIT - PIN

Florence, Tuscany, Italy, 50139

Actively Recruiting

16

Fujita Health University Hospital

Toyoake, Aichi-ken, Japan, 470-1192

Not Yet Recruiting

17

The Jikei University School of Medicine

Minato, Tokyo, Japan, 105-8471

Not Yet Recruiting

18

Erasmus MC

Rotterdam, South Holland, Netherlands, 3015 GD

Not Yet Recruiting

19

Hospital Sant Joan de Deu

Esplugues de Llobregat, Barcelona, Spain, 8950

Actively Recruiting

20

Hospital Universitario Marques de Valdecilla

Santander, Cantabria, Spain, 39008

Actively Recruiting

21

Hospital Universitario Cruces

Barakaldo, Spain, 48903

Actively Recruiting

22

Hospital Universitario Raymon y Cajal

Madrid, Spain, 28034

Actively Recruiting

23

Hospital Universitario 12 de Octubre

Madrid, Spain, 28041

Active, Not Recruiting

24

Hospital Universitario Virgen del Rocio - PPDS

Seville, Spain, 41013

Actively Recruiting

25

Hospital Universitari I Politecnic La Fe de Valencia

Valencia, Spain, 46026

Actively Recruiting

26

Victoria Hospital

Kirkcaldy, Fife, United Kingdom, KY2 5AH

Withdrawn

27

St Mary's Hospital - PPDS

Manchester, Lancashire, United Kingdom

Active, Not Recruiting

28

Great Ormond Street Hospital

City of London, London, United Kingdom

Active, Not Recruiting

29

University Hospital Birmingham

Birmingham, United Kingdom, B29 6JD

Actively Recruiting

Loading map...

Research Team

M

Moderna WeCare Team

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase 1/2, Global, Open-Label Extension Study to Evaluate ...

Propionic Acidemia

Actively Recruiting

22 locations

A Non-Interventional Post-Authorization Safety Study of Carb...

Hyperammonemia

Actively Recruiting

5 locations

Natural History, Physiology, Microbiome and Biochemistry Stu...

Metabolic Disease

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here